Recurrent complex ameloblastoma of infratemporal fossa in a young adult: a challenging case report

Authors

  • Praneeth Aregala Department of Surgical Oncology, Yashoda Super Specialty Hospitals, Somajiguda, Hyderabad, Telangana, India
  • Sachin Marda Department of Surgical Oncology, Yashoda Super Specialty Hospitals, Somajiguda, Hyderabad, Telangana, India
  • Sreehari Gowda Department of Surgical Oncology, Yashoda Super Specialty Hospitals, Somajiguda, Hyderabad, Telangana, India
  • Bhulaxmi Pullikanti Department of Pathology, Yashoda Super Specialty Hospitals, Somajiguda, Hyderabad, Telangana, India
  • T. M. Jyoshna Department of Surgical Oncology, Yashoda Super Specialty Hospitals, Somajiguda, Hyderabad, Telangana, India

DOI:

https://doi.org/10.18203/2349-2902.isj20253861

Keywords:

Ameloblastoma, Maxillary tumors, Infratemporal tumors, Complex facial tumors, Recurrent maxillary and mandibular tumors, Odontogenic tumor

Abstract

An uncommon, histologically benign, but aggressive, tumor of the jaws, ameloblastoma develops from odontogenic epithelium and has the capacity to extensively destroy jaw bones and infiltrate surrounding tissues. After incomplete treatment, recurrences are frequent. The orbit, anterior cerebral cavity, temporal and infratemporal fossa, and other challenging locations can experience recurrences. We report a case of recurrent complex cystic ameloblastoma over the right side of the face in a 31-year-old gentleman who presented with right facial swelling, serous discharge, intermittent pain, and decreased mouth opening for 2 years. Computed tomography (CT) head and neck with 3D reconstruction showed a complex solid-cystic multiloculated mass lesion in the right infratemporal fossa with large cystic components, septations, solid enhancing components, and peripheral calcifications, closely abutting the parotid gland, pterygoids, mandible, and maxillary antrum. Needful evaluation done. The patient underwent wide local excision of the tumor, right infrastructure maxillectomy, superficial parotidectomy, modified radical neck dissection, and microvascular alanine aminotransferase (ALT) free flap reconstruction. Complete surgical resection with negative margins is the hallmark for curative resection. Local recurrences are rare and usually amenable to re-resection. Postoperative radiotherapy for patients at increased risk of local recurrence improves local tumor control.

Metrics

Metrics Loading ...

References

Hong J, Yun PY, Chung IH, Myoung H, Suh JD, Seo BM, et al. Long-term follow up on recurrence of 305 ameloblastoma cases. Int J Oral Maxillofac Surg. 2007;36(4):283-8. DOI: https://doi.org/10.1016/j.ijom.2006.11.003

de Assis EM, Gomes HE, de Sousa FEM, Brener S, Leal RM, Souza PEA, et al. Recurrent peripheral ameloblastoma in an elderly patient: A case report. Gerodontology. 2019;36(1):78-81. DOI: https://doi.org/10.1111/ger.12377

Selvamani M, Yamunadevi A, Basandi PS, Madhushankari GS. Analysis of prevalence and clinical features of multicystic ameloblastoma and its histological subtypes in South Indian sample population: A retrospective study over 13 years. J Pharm Bioallied Sci. 2014;6:S131-4. DOI: https://doi.org/10.4103/0975-7406.137419

Covello P, Buchbinder D. Recent trends in the treatment of benign odontogenic tumors, Curr. Opin. Otolaryngol. Head Neck Surg. 2016;24(4):343-51. DOI: https://doi.org/10.1097/MOO.0000000000000269

Eckardt AM, Kokemüller H, Flemming P, Schultze A. Recurrent Ameloblastoma following osseous reconstruction--a review of twenty years. J Craniomaxillofac Surg. 2009;37:36-41. DOI: https://doi.org/10.1016/j.jcms.2008.07.009

Gilijamse M, Leemans CR, Winters HA, Schulten EA, van der Waal I. Metastasizing Ameloblastoma. Int J Oral Maxillofac Surg. 2007;36:462-4. DOI: https://doi.org/10.1016/j.ijom.2006.12.005

Carlson ER, Marx RE. The ameloblastoma: Primary, curative surgical management. J Oral Maxillofac Surg. 2006;64:484‑94. DOI: https://doi.org/10.1016/j.joms.2005.11.032

Hendra FN, Natsir Kalla DS, Van Cann EM, de Vet HCW, Helder MN, Forouzanfar T. Radical vs conservative treatment of intraosseous ameloblastoma: Systematic review and meta-analysis. Oral Dis. 2019;25:1683-96. DOI: https://doi.org/10.1111/odi.13014

Hasegawa T, Imai Y, Takeda D, Yasuoka D, Ri S, Shigeta T, et al. Retrospective study of ameloblastoma: the possibility of conservative treatment. Kobe J Med Sci. 2013;59:e112-21.

Bansal S, Desai RS, Shirsat P, Prasad P, Karjodkar F, Andrade N. The occurrence and pattern of ameloblastoma in children and adolescents: an Indian institutional study of 41 years and review of the literature. Int J Oral Maxillofac Surg. 2015;44:725-31. DOI: https://doi.org/10.1016/j.ijom.2015.01.002

Antonoglou GN, Sándor GK. Recurrence rates of intraosseous ameloblastomas of the jaws: a systematic review of conservative versus aggressive treatment approaches and meta-analysis of nonrandomized studies. J Craniomaxillofac Surg. 2015;43:149-57. DOI: https://doi.org/10.1016/j.jcms.2014.10.027

Downloads

Published

2025-11-26

How to Cite

Aregala, P., Marda, S., Gowda, S., Pullikanti, B., & Jyoshna, T. M. (2025). Recurrent complex ameloblastoma of infratemporal fossa in a young adult: a challenging case report . International Surgery Journal, 12(12), 2222–2225. https://doi.org/10.18203/2349-2902.isj20253861

Issue

Section

Case Reports